GET IN TOUCH
Have questions?
Contact our client services team today.
- services@mplnet.com
- 865.380.9746
- 250 E. Broadway Maryville, TN 37804
Test from a single liquid cytology specimen
(ThinPrep® PAP solution or SurePath™ Test Pack) for:
MPLN has always been at the forefront of laboratory medicine and inspired the genesis of women’s health testing using liquid cytology and molecular diagnostics. As a result of MPLN’s significant involvement in STI-related clinical trials, MPLN has access to the latest advances in technology and automation and shares these innovations with our pathology clients. MLPN continually updates clinical diagnostic testing platforms and assays to enable us to focus on better patient outcomes and reducing costs.
MPLN now offers the Hologic GenProbe APTIMA® HPV 16 18/45 Genotype Assay, which identifies the two most highly oncogenic and persistent high-risk HPV types known to cause high-grade cervical neoplasia. The assay also facilitates risk stratification of patients at greater risk for cervical disease to tailor care more appropriately.
Women’s health tests available from MPLN on ThinPrep® PAP and SurePathTM Test Pack liquid cytology media include HPV High Risk, HPV 16 14/45 Genotype, Chlamydia trachomatis, Neisseria gonorrhea, Herpes simplex, and Trichomonas vaginalis.
MPLN has been at the forefront of laboratory medicine and has been instrumental in developing women’s health testing through liquid cytology and molecular diagnostics. MPLN’s involvement in STI-related clinical trials has given us access to the latest technology and automation, which we share with our pathology clients. MPLN continuously updates its clinical diagnostic testing platforms and assays to enable better patient outcomes and reduce costs.
MPLN now offers the Hologic GenProbe APTIMA® HPV 16 18/45 Genotype Assay, which identifies the two most highly oncogenic and persistent high-risk HPV types known to cause high-grade cervical neoplasia. The assay also facilitates risk stratification of patients at greater risk for cervical disease in order to tailor care more appropriately.
MPLN provides women’s health tests on ThinPrep® PAP and SurePathTM Test Pack liquid cytology media. These tests include HPV High Risk, HPV 16 14/45 Genotype, Chlamydia trachomatis, Neisseria gonorrhea, Herpes simplex, and Trichomonas vaginalis.
Provides enhanced testing, refined results, and offers
the following benefits:
Contact our client services team today.